Canada markets closed

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.9600+0.0800 (+4.26%)
At close: 04:00PM EDT
1.9100 -0.05 (-2.55%)
After hours: 06:48PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 21.68M
Enterprise Value 25.36M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)15.08
Price/Book (mrq)0.74
Enterprise Value/Revenue 19.48
Enterprise Value/EBITDA -3.34

Trading Information

Stock Price History

Beta (5Y Monthly) 1.04
52-Week Change 3-51.03%
S&P500 52-Week Change 322.38%
52 Week High 34.7200
52 Week Low 31.8500
50-Day Moving Average 32.1884
200-Day Moving Average 32.6790

Share Statistics

Avg Vol (3 month) 323.25k
Avg Vol (10 day) 314.54k
Shares Outstanding 511.53M
Implied Shares Outstanding 611.53M
Float 89.91M
% Held by Insiders 11.90%
% Held by Institutions 143.63%
Shares Short (Apr 15, 2024) 445.91k
Short Ratio (Apr 15, 2024) 41.63
Short % of Float (Apr 15, 2024) 40.48%
Short % of Shares Outstanding (Apr 15, 2024) 40.40%
Shares Short (prior month Mar 15, 2024) 447.38k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3May 09, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-320.92%

Management Effectiveness

Return on Assets (ttm)-7.96%
Return on Equity (ttm)-23.90%

Income Statement

Revenue (ttm)1.3M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)-99.30%
Gross Profit (ttm)N/A
EBITDA -8.4M
Net Income Avi to Common (ttm)-7.7M
Diluted EPS (ttm)-0.7800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.33M
Total Cash Per Share (mrq)0.38
Total Debt (mrq)8.01M
Total Debt/Equity (mrq)27.33%
Current Ratio (mrq)1.72
Book Value Per Share (mrq)2.54

Cash Flow Statement

Operating Cash Flow (ttm)-48.14M
Levered Free Cash Flow (ttm)-34.19M